Scyllo-Inositol Pharmaceutical Grade from Japan
Scyllo-inositol is an inositol stereoisomer researched for Alzheimer's treatment, classified under HTS 2906.13.10.00 as a pure cyclic alcohol. It meets pharmacopeia standards for use in clinical trials and drug development.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Include USP/EP certificate of analysis proving ≥98% purity to maintain Chapter 29 classification
• Declare intended use as bulk API; finished dosage forms reclassify to Chapter 30
• Monitor for DEA scheduling if combined with other actives, though pure inositols are unregulated